臨床薬理の進歩 No.42
75/228

¨1)American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Publishing, 2013.2)Minnis H, Messow CM, McConnachie A, Bradshaw P, Briggs A, Wilson P, et al. Autism and attachment disorder symptoms in the general population: Prevalence, overlap, and burden. Developmental Child Welfare 2020; 2: 37-51.3)Shimada K, Takiguchi S, Mizushima S, Fujisawa TX, Saito DN, Kosaka H, et al. Reduced visual cortex grey matter volume in children and adolescents with reactive attachment disorder. Neuroimage Clin 2015; 9: 13-9.4)Makita K, Takiguchi S, Naruse H, Shimada K, Morioka S, Fujisawa TX, et al. White matter changes in children and adolescents with reactive attachment disorder: A diffusion tensor imaging study. Psychiatry Res Neuroimaging 2020; 303: 111129.5)Jung M, Takiguchi S, Hamamura S, Mizuno Y, Kosaka H, Tomoda A. Thalamic volume is related to increased anterior thalamic radiations in children with reactive attachment disorder. Cereb Cortex 2020; 30: 4238-45. 6)Takiguchi S, Fujisawa TX, Mizushima S, Saito DN, Okamoto Y, Shimada K, et al. Ventral striatum dysfunction in children and adolescents with reactive attachment disorder: functional MRI study. BJPsych Open 2015; 1: 121-8.7)Harari-Dahan O, Bernstein A. A general approach-avoidance hypothesis of oxytocin: accounting for social and non-social effects of oxytocin. Neurosci Biobehav Rev 2014; 47: 506-19.8)DeMayo MM, Song YJC, Hickie IB, Guastella AJ. A Review of the safety, efficacy and mechanisms of delivery of nasal oxytocin in children: Therapeutic potential for autism and Prader-willi syndrome, and recommendations for future research. Paediatr Drugs 2017; 19: 391-410.9)Suzuki S, Fujisawa TX, Sakakibara N, Fujioka T, Takiguchi S, Tomoda A. Development of social attention and oxytocin levels in maltreated children. Sci Rep 2020; 10: 7407.10)Goodman R. The strengths and difficulties questionnaire: a research note. J Child Psychol Psychiatry 1997; 38: 581–6.11)Domes G, Ower N, von Dawans B, Spengler FB, Dziobek I, Bohus M, et al. Effects of intranasal oxytocin administration on empathy and approach motivation in women with borderline personality disorder: a randomized controlled trial. Transl Psychiatry 2019; 9: 328.12)Groppe SE, Gossen A, Rademacher L, Hahn A, Westphal L, Grunder G, et al. Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain. Biol Psychiatry 2013; 74: 172-9.13)Pochon JB, Levy R, Fossati P, Lehericy S, Poline JB, Pillon B, et al. The neural system that bridges reward and cognition in humans: an fMRI study. Proc Natl Acad Sci U S A 2002; 99: 5669-74.14)Peng K, Steele SC, Becerra L, Borsook D. Brodmann area 10: Collating, integrating and high level processing of nociception and pain. Prog Neurobiol 2018; 161: 1-22.15)Eckstein M, Becker B, Scheele D, Scholz C, Preckel K, Schlaepfer TE, et al. Oxytocin facilitates the extinction of conditioned fear in humans. Biol Psychiatry 2015; 78: 194-202.16)Novick AM, Levandowski ML, Laumann LE, Philip NS, Price LH, Tyrka AR. The effects of early life stress on reward processing. J Psychiatr Res 2018; 101: 80-103.17)Nawijn L, van Zuiden M, Koch SBJ, Frijling JL, Veltman DJ, Olff M. Intranasal oxytocin enhances neural processing of monetary reward and loss in post-traumatic stress disorder and traumatized controls. Psychoneuroendocrinology 2016; 66: 228-37.18)Greene RK, Spanos M, Alderman C, Walsh E, Bizzell J, Mosner MG, et al. The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder. J Neurodev Disord 2018; 10: 12.文  献61

元のページ  ../index.html#75

このブックを見る